FAO Regional Office for Europe and Central Asia

Stakeholder network meeting on country initiatives to tackle antimicrobial resistance in food and agriculture in Kyrgyzstan

Bishkek (Kyrgyzstan), 02/07/2024

In line with its mandate for food and agriculture sectors and overall initiatives on antimicrobial resistance (AMR), FAO has been working with the Government of Kyrgyzstan to revise regulatory and legal framework and policies regarding the use of antimicrobials, assess and support the establishment and the improvement of laboratory capacities and antimicrobial resistance surveillance, and assist and facilitate multi-sectoral coordination and strategic advocacy on the risks related to AMR for humans, food, animals, plants and the environment. More specifically, key activities to understand antimicrobial use in livestock production and enhance laboratory capacities to detect and characterize AMR and obtain baseline surveillance data were conducted in Kyrgyzstan. These include antimicrobial use surveys in livestock production, the national capacity assessment using the FAO Assessment Tool for Laboratories and AMR Surveillance Systems (FAO-ATLASS), AMR laboratory training, pilot implementation of AMR surveillance study. 

As results are now available for these specific activities, FAO, in collaboration with the Ministry of Agriculture of the Kyrgyz Republic, Veterinary service under the Ministry, the Ministry of Health, Kyrgyz Research Institute of Veterinary, Kyrgyz National Agrarian University, Dairy Association of the Kyrgyz Republic, Chamber of Beekeepers of the Kyrgyz Republic will organize a national stakeholder meeting held on 2 July 2024 in Bishkek with the aim to share and discuss the results and possible follow up activities.

The meeting aims to provide a platform to:
• Exchange updates on antimicrobial use and resistance initiatives and results in the country for the food and agriculture sectors.
• Discuss and take stock on possible follow up initiatives, including support for joining FAO-lead initiatives on antimicrobial use, resistance and residues laboratory capacity buildings and surveillance.